Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_provenance.
- NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_assertion description "[Identification of the molecular determinants of 5-fluorouracil (5-FU) and irinotecan (CPT-11) efficacy and toxicity is critically important for the development of more efficient and less toxic treatment strategies for patients with colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_provenance.
- NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_assertion evidence source_evidence_literature NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_provenance.
- NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_assertion SIO_000772 11177741 NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_provenance.
- NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_assertion wasDerivedFrom befree-2016 NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_provenance.
- NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_assertion wasGeneratedBy ECO_0000203 NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP307278.RA-itOc8fQ2o3DXxRJYKzk16vRjTkpb-wRvjgw17A0CLQ130_provenance.